en

PRODUCT DETAIL

Iclusig 15 mg filmom obalené tablety

Code 6384A
MA number EU/1/13/839/001
Product Form: tbl flm 60x15 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA05 Ponatinib
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 01.07.2013
SmPC + PL: European Medicines Agency's database
Dokument: DHPC letter_BCR-ABLTKIs_SK 11 4 2016.pdf  
Safety feature Yes
Data update: 20.07.2021
eu-flag.png sk-flag.png